BioPharma Credit PLC (MUN:B3P)

Market Cap	942.37M +8.7%
Revenue (ttm)	134.35M +5.1%
Net Income	110.62M +6.3%
EPS	0.10 +14.0%
Shares Out	n/a
PE Ratio	8.52
Forward PE	n/a
Dividend	0.09 (9.83%)
Ex-Dividend Date	Jul 2, 2026

Volume	600
Open	0.8550
Previous Close	n/a
Day's Range	0.8450 - 0.8650
52-Week Range	0.7550 - 0.8650
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: Munich Stock Exchange
• Ticker Symbol: B3P

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 26, 2026

Data Sources Report a data error